loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Ridinilazole

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Ridinilazole

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Summit Therapeutics Presents Ri-CoDIFy Trial Results for Ridinilazole at IDWeek
    Summit Therapeutics Presents Ri-CoDIFy Trial Results for Ridinilazole at IDWeek

    20 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/20/2538895/0/en/Summit-Therapeutics-Presents-Ri-CoDIFy-Trial-Results-for-Microbiome-Sparing-Ridinilazole-at-IDWeek-2022.html

    GLOBENEWSWIRE
    20 Oct 2022
    Share Share
    Summit to Present Ri-CoDIFy Trial Results for Microbiome-Sparing Ridinilazole
    Summit to Present Ri-CoDIFy Trial Results for Microbiome-Sparing Ridinilazole

    13 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/13/2533796/0/en/Summit-Therapeutics-to-Present-Ri-CoDIFy-Trial-Results-for-Microbiome-Sparing-Ridinilazole-at-IDWeek-2022.html

    GLOBENEWSWIRE
    13 Oct 2022
    Share Share
    Summit Therapeutics Provides Update on Ridinilazole
    Summit Therapeutics Provides Update on Ridinilazole

    14 Jul 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/07/14/2479712/0/en/Summit-Therapeutics-Provides-Update-on-Ridinilazole.html

    GLOBENEWSWIRE
    14 Jul 2022
    Share Share
    Summit will take scenic route up FDA mountain
    Summit will take scenic route up FDA mountain

    14 Jul 2022

    // Annalee Armstrong FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/summit-will-take-scenic-route-fda-mountain-after-c-diff-convo-regulator

    Annalee Armstrong FIERCEBIOTECH
    14 Jul 2022
    Share Share
    Summit turns to partnerships for failed C. difficile med
    Summit turns to partnerships for failed C. difficile med

    19 Mar 2022

    // Max Bayerf FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/summit-carves-out-path-forward-after-c-diff-failure-remains-committed-lead-asset

    Max Bayerf FIERCEBIOTECH
    19 Mar 2022
    Share Share
    Bob Duggan's new antibiotic play fails a Phase III trial; upsets investors
    Bob Duggan's new antibiotic play fails a Phase III trial; upsets investors

    22 Dec 2021

    // N. DeFeudis ENDPTS

    https://endpts.com/billionaire-bob-duggans-new-antibiotic-play-fails-a-phase-iii-trial-and-investors-arent-happy/

    N. DeFeudis ENDPTS
    22 Dec 2021
    Share Share